glutathione levels in cancer cells Reduced GCLC expression and de novo synthesis pancreatic Glutathione-mediated nanomedicines for cancer diagnosis

Preclinical potency benchmark Tomas et al

In a human study Clinical Glutathione was found to improve the ratio of active form of glutathione (reduced glutathione) to the inactive form (oxidized) in the body by 230%

Ciftci H, Verit A, Savas M, et al

The study was aimed at determining the efficiency and safety of use of three MIG-99 doses, 2.08, 6.25, and 18.75 mg versus placebo, in a group of 147 patients with diagnosed migraine (with and without aura)

It facilitates the cellular movement and remodeling for reorganizing injured tissue

The main benefits of employing the ME approach are the prolonged and regulated distribution of medications, targeted therapy, extended and controlled distribution of pharmaceuticals, increased shelf life, stabilization, and immobility of microbes and enzymes (Meng et al., 2023)